Giovanni Caforio, MD, Chairman of the Board & CEO, Bristol Myers Squibb

Giovanni Caforio, MD, has been chief executive officer of Bristol Myers Squibb since May 2015. As CEO, Giovanni has led the company’s focus on researching and developing transformational medicines, which includes a leading portfolio of immunotherapies that are fundamentally changing the way cancer is treated. With a background as a physician, Giovanni has helped strengthen the company’s patient-focused culture — one driven by innovation, speed, accountability and passion. As a leader, he is focused on the business value of a company culture that promotes and rewards diversity and inclusion. Prior to becoming CEO, Giovanni held roles of increasing responsibility at the company, and prior to BMS, Giovanni spent 12 years with Abbott Laboratories in a number of leadership positions. Born and educated in Italy, Giovanni received his MD from the University of Rome.